You have 4 free searches left this month | for more free features.

21-206

Showing 26 - 50 of 6,747

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Stage III, Melanoma Stage IV Trial in Boston, Rochester, Houston (SX-682, Pembrolizumab)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Boston, Massachusetts
  • +4 more
Jan 26, 2022

NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)

Recruiting
  • Non-small Cell Lung Cancer
  • Jette, Brussel, Belgium
    Universitair Ziekenhuis Brussel
Jun 27, 2023

Newly Diagnosed Glioblastoma Trial (combinations of up to 3 FDA approved drugs from a panel of compounds)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • combinations of up to 3 FDA approved drugs from a panel of compounds
  • (no location specified)
Jan 19, 2023

Advanced Solid Tumor Trial in Australia, China, Hong Kong (HBM4003)

Active, not recruiting
  • Advanced Solid Tumor
  • Kogarah, New South Wales, Australia
  • +16 more
Aug 2, 2022

Pain Management Trial in Baghdad (Non-pharmacological pain management strategies)

Completed
  • Pain Management
  • Non-pharmacological pain management strategies
  • Baghdad, Iraq
    College of Nursing- The University of Baghdad
Jul 12, 2023

Paternal Age and Fetal Aneuploidy

Active, not recruiting
  • Trisomy 21
  • Optimo prenatal screening test
  • MontrĂ©al, Quebec, Canada
    Clinique Ovo
Aug 7, 2023

Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +8 more
  • Polatuzumab Vedotin
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Vision Screening Study for College Students at Nankai University

Completed
  • Myoma
  • No intervention
  • Tianjin, Tianjin, China
    Tiajin Eye Hospital
Jun 28, 2023

Stress, Anxiety Trial in Boston (PRISM Program Video Coach, PRISM Program Text Coach, mPRISM Program App)

Not yet recruiting
  • Stress
  • Anxiety
  • PRISM Program Video Coach
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 8, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Study of Subjects Who Received ICM-203 or Matching Placebo

Not yet recruiting
  • Osteoarthritis, Knee
  • ICM-203
  • Placebo
  • Adelaide, South Australia, Australia
  • +1 more
Feb 21, 2023

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Adolescent Behavior Trial in Seattle (Media Discussion and Planning Tool (MDPT))

Not yet recruiting
  • Adolescent Behavior
  • Media Discussion and Planning Tool (MDPT)
  • Seattle, Washington
    Seattle Children's Hospital
Feb 1, 2023

Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Seattle (drug, other,

Recruiting
  • Recurrent Hodgkin Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2022

Aerobic Endurance, Metabolism Trial in Natick (High-amylose maize starch+acetate/butyrate, Low-amylose maize starch)

Recruiting
  • Aerobic Endurance
  • Metabolism
  • High-amylose maize starch+acetate/butyrate
  • Low-amylose maize starch
  • Natick, Massachusetts
    United States Army Research Institute of Environmental Medicine
Sep 19, 2023

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial

Completed
  • Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
  • Houston, Texas
    M.D. Anderson Cancer Center
Aug 22, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Chronic Cough Trial in Worldwide (Gefapixant, Placebo)

Completed
  • Chronic Cough
  • Phoenix, Arizona
  • +90 more
Sep 19, 2022

NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)

Completed
  • NAFLD
  • Soy isoflavone
  • Placebo
  • Ahvaz, Khuzestan, Iran, Islamic Republic of
    Asal Neshatbini Tehrani
Oct 24, 2023

Motility Function Trial in San Francisco (High resolution solid state manometry)

Not yet recruiting
  • Motility Function
  • High resolution solid state manometry
  • San Francisco, California
    University of California, San Francisco
Oct 6, 2022

Drug-drug Interactions Between Hormonal Contraceptives and

Recruiting
  • HIV Infections
  • +2 more
  • Etonogestrel (ETG) implant
  • +3 more
  • Johannesburg, South Africa
    Wits Reproductive Health and HIV Institute, Research Centre Clin
Feb 28, 2022

Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)

Recruiting
  • Malignant Pleural Mesothelioma
  • Safety
  • Expansion Cohort
  • New York, New York
    Icahn School of Medicine Mount Sinai
Mar 31, 2022

Metastatic Solid Tumors Trial in Scottsdale, Santa Monica (aldoxorubicin, gemcitabine)

Completed
  • Metastatic Solid Tumors
  • Scottsdale, Arizona
  • +1 more
Jan 27, 2022